Projects per year
Personal profile
Headline
Biography
Fingerprint
- 1 Similar Profiles
Network
-
A novel treatment option for disorders of propionate metabolism
Houten, S., DeVita, R., Houten, S. M. & Devita, R. R. J.
National Institute of Child Health and Human Development
22/09/21 → 31/08/23
Project: Research
-
Substrate reduction as a novel therapeutic strategy for Glutaric Aciduria Type 1
Houten, S., DeVita, R., Houten, S. M. & Devita, R. R. J.
National Institute of Child Health and Human Development
1/05/21 → 30/04/23
Project: Research
-
Modulate Cullin-RING E3 ubiquitin ligases by small molecule agents
Pan, Z., DeVita, R., Pan, Z. & Devita, R. R. J.
1/07/20 → 30/06/23
Project: Research
-
Novel Selective Type II kinase Inhibitors to treat Diabetes
DeVita, R., Stewart, A., Devita, R. J. & Stewart, A. F.
National Institute of Diabetes and Digestive and Kidney Diseases
1/04/18 → 28/02/23
Project: Research
-
Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1
Leandro, J., Khamrui, S., Suebsuwong, C., Chen, P. J., Secor, C., Dodatko, T., Yu, C., Sanchez, R., Devita, R. J., Houten, S. M. & Lazarus, M. B., 21 Sep 2022, In: Open Biology. 12, 9, 220179.Research output: Contribution to journal › Article › peer-review
Open Access -
DYRK1A Inhibitors as Potential Therapeutics for β-Cell Regeneration for Diabetes
Kumar, K., Suebsuwong, C., Wang, P., Garcia-Ocana, A., Stewart, A. F. & Devita, R. J., 25 Mar 2021, In: Journal of Medicinal Chemistry. 64, 6, p. 2901-2922 22 p.Research output: Contribution to journal › Review article › peer-review
13 Scopus citations -
Food colorants metabolized by commensal bacteria promote colitis in mice with dysregulated expression of interleukin-23
He, Z., Chen, L., Catalan-Dibene, J., Bongers, G., Faith, J. J., Suebsuwong, C., DeVita, R. J., Shen, Z., Fox, J. G., Lafaille, J. J., Furtado, G. C. & Lira, S. A., 6 Jul 2021, In: Cell Metabolism. 33, 7, p. 1358-1371.e5Research output: Contribution to journal › Article › peer-review
Open Access26 Scopus citations -
Human Beta Cell Regenerative Drug Therapy for Diabetes: Past Achievements and Future Challenges
Wang, P., Karakose, E., Choleva, L., Kumar, K., DeVita, R. J., Garcia-Ocaña, A. & Stewart, A. F., 16 Jul 2021, In: Frontiers in Endocrinology. 12, 671946.Research output: Contribution to journal › Review article › peer-review
Open Access10 Scopus citations -
Inhibitors of cullin-RING E3 ubiquitin ligase 4 with antitumor potential
Wu, K., Huynh, K. Q., Lu, I., Moustakim, M., Miao, H., Yu, C., Haeusgen, M. J., Hopkins, B. D., Huang, L., Zheng, N., Sanchez, R., DeVita, R. J. & Pan, Z. Q., 23 Feb 2021, In: Proceedings of the National Academy of Sciences of the United States of America. 118, 8, e2007328118.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations
Press / Media
-
Australia Patent: Application for 'Kinase inhibitor compounds and compositions and methods of use' Lapses
Chalada Suebsuwong, Robert DeVita & Peng Wang
12/01/23
1 item of Media coverage
Press/Media
-
Kinase Inhibitor Compounds and Compositions and Methods of Use
Robert DeVita, Avner Schlessinger & Andrew Stewart
10/01/23
1 item of Media coverage
Press/Media
-
Sprint Bioscience: Sprint Bioscience appoints Scientific Advisory Board (MFN)
11/05/22
1 item of Media coverage
Press/Media
-
JDRF Recognizes Mount Sinai’s Contribution to Diabetes Research and Patient Care
joan han, Joan Han, Andrea Dunaif, Robert DeVita, Carol Levy, Andrew Stewart & Peng Wang
30/04/22
1 item of Media coverage
Press/Media